Barclays and Unreasonable,select 1mg Technologies to receive $100,000


Deprecated: strlen(): Passing null to parameter #1 ($string) of type string is deprecated in /home/medicircle/public_html/script_newsdetails.php on line 75
▴ barclays-unreasonable-selects-top-innovations
Unreasonable Impact is an innovative multi-year multi-geographic partnership between Barclays and Unreasonable Group to support entrepreneurs

1mg Technologies has been awarded a $100,000 grant in recognition of the exceptional work being undertaken in addressing the immediate and long term challenges resulting from the effects of the global pandemic.

Unreasonable Impact COVID-19 Response is a new initiative launched by Barclays and Unreasonable Group awarding $100,000 grants each to ten Unreasonable ventures that have pivoted their businesses to combat challenges related to COVID-19. The grant is designed to support and amplify the impact of the work 1mg Technologies is doing.

The initiative was launched as a direct response to the outbreak of COVID-19 and is an extension of Unreasonable Impact, the unique multi-year partnership between the two companies supporting growth-stage entrepreneurs across the Americas, Europe and Asia Pacific regions solving many of the world's most pressing issues.

1mg was chosen by a selection committee for the meaningful work they are doing in India of ensuring access to healthcare essential services at home such as the delivery of medicines at home for millions of families in India, COVID-19 testing, etc. 1mg is helping families stay at home and stay safe. Prashant Tandon, 1mg's Co-founder & CEO said, "We are extremely happy to receive this global recognition and grant. Our frontliners are working non-stop amidst the pandemic to ensure millions of families have access to healthcare services at their doorsteps. Our courageous fleet of frontliners continues to serve our nation selflessly and this recognition further strengthens our belief in the advantages of digital-led healthcare models."

1mg's Co-founder & CEO will join the nine other recipients at a live virtual event, The Unreasonable Impact COVID-19 Response Global Summit, created with Barclays on July 8th where he will have a chance to share his team's exceptional work with a global audience.

Joe McGrath, Barclays' Global Head of Banking, commented, "Through Unreasonable Impact, we set out to help entrepreneurs take their businesses to the next level. They are already tackling almost impossible-sounding challenges, so when COVID-19 took hold we weren't surprised that they would point their talent and drive towards responding to the pandemic. We're in awe of the speed that they've pivoted their businesses and of the positive impact that they've already made, so we're delighted to be able to support them through the Unreasonable Impact COVID-19 Response."

Daniel Epstein, Founder and CEO of Unreasonable Group, added, "Unreasonable Impact was co-created with Barclays with a shared intention to support and scale up entrepreneurial solutions to the world's most pressing challenges. The global impact of COVID-19 is unlike any challenge any of us has seen in our lifetimes. Setting up the COVID-Response to support and amplify ventures leveraging business to combat challenges related to the pandemic is a natural extension of our mission. We are humbled to be supporting the exceptional workof1mg Technologies."

Full list of ventures selected:

1MG Technologies: India's leading mobile healthcare platform with over 9 million downloads and 33 million monthly visits

80 Acres Farms: Converting urban spaces in ultra-efficient indoor farms that produce accessible, tasty and affordable local food year-round

Airlabs: Transforming polluted cities into clean air zones by removing 95% nitrogen dioxide along with all other pollutants from the air

Day Owl: Turning trash from the poorest neighborhoods in the world into purpose-filled recycled fabrics

Ecoware: Creating 100% biodegradable eco-friendly and compostable certified food packaging and garbage bags

eFishery: Creating the future of aquaculture with an IoT smart feeding technology to help hundreds of millions of farmers at the bottom of the pyramid

Globechain: Creating the world's largest reuse marketplace that connects corporates to charities and people to redistribute unwanted items

Nanobiosym: Using nanotechnology to empower people worldwide with rapid affordable and portable diagnostic information about their own health

Olio: connecting neighbors and local shops so surplus food and other household items can be shared rather than thrown away

Zero Mass: Making drinking water an ultimate resource with SOURCE, a set of panels that make water from the air

Tags : #BarclaysBank #UnreasonableImpact #NewInitiative #TopInnovations #1mgTechnologies

About the Author


Team Medicircle

Related Stories

Loading Please wait...

-Advertisements-



Trending Now

CARE Hospitals to Offer Free Vascular Health Check on National Vascular DayAugust 05, 2026
Breastfeeding Myths That New Mothers Should Stop BelievingAugust 05, 2026
Why Modern Lifestyle Causes Chronic InflammationAugust 05, 2026
Endometriosis Awareness: Understanding the Silent Condition Affecting Millions of Indian WomenAugust 05, 2026
A Complete Guide to Pregnancy Health Tips for Indian Women: Nutrition, Wellness, and What Every Expectant Mother Should KnowAugust 05, 2026
Metropolis Healthcare reports strong Q1FY27 performance, with revenue up 17% to ₹450 crore and EBITDA up 27% YoYAugust 04, 2026
India's Silent Liver Health Crisis: New Data Points to Urgent Need for Screening and PreventionAugust 04, 2026
Eureka Forbes Launches 'Ghar Ka New Favourite' Campaign showcasing Forbes SmartClean Robotic Vacuum Cleaner with Shraddha KapoorAugust 04, 2026
Why Preventive Healthcare for Children Is One of the Most Important Investments India Can MakeAugust 04, 2026
The Role of Pathology in Healthcare: From Diagnosis to Disease PreventionAugust 04, 2026
Pathophysiology of Psoriatic Arthritis: Clinical Presentation, Joint Damage Mitigation, and BiologicsAugust 04, 2026
Comprehensive Evaluation of Syncope: Cardiac vs. Neurological Origin WorkupsAugust 04, 2026
Common Medical Terms Explained: A Plain-Language Guide for Indian Patients and Healthcare SeekersAugust 03, 2026
Why Radiology Is the Backbone of Modern Medical Diagnosis and TreatmentAugust 03, 2026
Managing Urban Stress: Science-Backed Strategies for Mental Resilience in 2026 August 01, 2026
Managing Chronic Inflammation: The Role of Anti-Inflammatory Indian SuperfoodsAugust 01, 2026
Pathophysiology of Psoriatic Arthritis: Clinical Presentation, Joint Damage Mitigation, and BiologicsAugust 01, 2026
Early Markers of Glaucoma: Structural vs. Functional Ophthalmic Diagnostic ProtocolsAugust 01, 2026
Managing Complex Diabetic Foot Ulcers: Multidisciplinary Wound Care, Offloading, and RevascularizationAugust 01, 2026
The Future of Preventive Medicine: How India Is Moving From Cure to PreventionAugust 01, 2026